DB15007InvestigationalSmall molecule
Sevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin).
- Mechanism
- Curator reviewed
Pharmacologically active on von Willebrand factor, P-selectin, and Fibronectin
Resolves to
Compound
What you can answer from here — as of July 08, 2026
Which drugs share a target with Sevuparin, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account